Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

CLX · Q3 2026 Earnings

Clorox

Reported April 30, 2026

30-second summary

Clorox cut FY2026 adjusted EPS guidance to $5.45–$5.65 from $5.95–$6.30 (an 8–10% reduction at the midpoint), pushed organic sales to the worst end of the prior -5% to -9% range, and tripled the gross margin decline guide to -250 to -300 bps from -50 to -100 bps. Net sales guidance was narrowed to the favorable end of the prior range (down about 6% vs. prior down 6% to 10%). Q3 itself was mixed — organic sales -1%, gross margin 43.2%, adjusted EPS $1.64 — but the story is the FY2026 walk: EPS, organic sales, and gross margin all moved lower, Lifestyle fell 9%, and management acknowledged "the pace of improvement has been slower than we expected." The H2 inflection that the Q1 and Q2 briefs flagged as conditional has not materialized, and the new gross margin guide imports higher energy costs and Gojo dilution as fresh structural headwinds.

Headline numbers

EPS

Q3 FY2026

$1.64

Revenue

Q3 FY2026

$1.67B

+0.0% YoY

Gross margin

Q3 FY2026

43.2%

Key financials

Q3 FY2026

Metric	Q3 FY2026	YoY	Q2 FY2026	QoQ
Revenue	$1.67B	+0.0%	$1.67B	-0.2%
EPS	$1.64	—	$1.39	+18.0%
Gross margin	43.2%	—	43.2%	+0bps

Guidance

Company slashed full-year FY2026 guidance across all metrics, with adjusted EPS down 8-10%, organic sales at worst end of prior range (-9%), and gross margin guidance deteriorating by 150-200bps due to cost inflation and ERP headwinds.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EPS	FY 2026	$5.95 to $6.30	$5.45 to $5.65	-$0.50 to -$0.65 (low end down 8.4%, high end down 10.3%)	Lowered
Net Sales Growth	FY 2026	down 6% to 10%	down about 6%	Narrowed to midpoint of prior range; now expecting -6% vs. prior range -6% to -10%	Lowered
Organic Sales Growth	FY 2026	down 5% to 9%	decrease about 9%	Shifted to high end of prior range; now -9% vs. prior range -5% to -9%	Lowered
Gross Margin	FY 2026	down 50 to 100 basis points	down 250 to 300 basis points	-150 to -200 basis points worse than prior guidance	Lowered
GAAP EPS	FY 2026	$5.60 to $5.95	$4.78 to $4.98	-$0.82 to -$0.97 (low end down 14.6%, high end down 16.3%)	Lowered

Segment performance

Q3 FY2026

Segment	Q3 FY2026	YoY
Health and Wellness	$0.629B	—
Household	$0.482B	+3.0%
Lifestyle	$0.277B	-9.0%
Adjusted EBIT - Health and Wellness	$158M	—
Adjusted EBIT - Household	$74M	—
Adjusted EBIT - Lifestyle	$60M	—

Platform metrics

Q3 FY2026

Segment	Q3 FY2026
Organic Sales Growth	-1%
Organic Sales Growth (Full Year 2026 Outlook)	-9%

Profitability

Q3 FY2026

Segment	Q3 FY2026
Gross Margin	43.2%
Full Year 2026 Adjusted EPS Outlook	$5.45 - $5.65

Other KPIs

Q3 FY2026

Segment	Q3 FY2026	YoY
International	$0.285B	+8.0%
Adjusted EBIT - International	$36M	—

Management tone

Q4 own-goal acknowledgement → Q1 walked-back recovery confidence → Q2 price-investment capitulation → Q3 broad-based guide cut and FY27 hedge.

Three quarters ago ERP was framed as transitory; this quarter it pushes cost savings into FY27. At Q4 FY2025, Bellet called the ERP margin impact "just noise between years and nothing structural." Last quarter the implementation was declared complete. This quarter Luke acknowledged "we had to further delay some cost savings…some will go in Q4, and some of Q4 will go in next year." The implementation finished, but the financial drag did not — it migrated forward into FY27, joining oil and Gojo dilution as fresh structural items in the gross margin walk. The "noise between years" framing is now untenable; the cost savings the company expected to harvest from ERP completion have been pushed out at least 12 months.

Pricing posture has hardened to "discipline and caution." This quarter Linda said the company is "approaching this with a high level of discipline and caution. We know the consumer is under stress, and our absolute number one priority is to ensure that we are driving improvements in value superiority." Pricing is now a constrained surgical exercise — the company explicitly signaled it would consider "potential targeted pricing" only "subject to" conditions. That is the language of a company that has lost confidence its brand premium can absorb cost inflation.

Consumer narrative is now bifurcated within a single call. Linda used both framings on this call: "the consumer is under stress, and you could argue a lot more stress now given what they're experiencing from gas prices and just the uncertainty," alongside "generally, again, the consumer is pretty resilient in our categories." Rather than a clean quarter-over-quarter tone shift, the company is now publicly holding both views simultaneously — acknowledging a deteriorating macro backdrop while leaning on category resilience as the bull case. Coupled with the Middle East conflict being introduced as a fresh external — never mentioned in prior quarters — the macro overlay has hardened.

Innovation execution narrative bifurcated for the first time. Through Q1 and Q2, innovation was a monolithic back-half lever. This quarter Linda separated it: cleaning and food innovation is working; litter "is going to be just bumpier. And it's not totally unexpected given the amount of transformation we're taking on there." That "not totally unexpected" softens the miss but admits the company knew the litter conversion was high-risk. The H2 innovation ramp that anchored the FY guide is now explicitly partial.

Forward-looking confidence is at a multi-quarter low. Bellet's FY27 commentary — "it's too early to share any perspective for next fiscal year…we're currently working on next fiscal year, working on a wide range of scenarios" — is materially more hedged than the typical Clorox forward framing. Combined with multiple pieces of hedging language in the prepared remarks, the message is that management has lost visibility into the FY27 cost and demand setup.

Recurring themes management leaned on this quarter:

ERP disruption and stabilization creating margin headwinds with delayed cost savingsLitter category reinvention proving slower-converting than expected despite innovation strength elsewhereOil-related commodity cost inflation creating material margin pressure ($20-25M in Q4)Shift toward targeted RGM and trade optimization over broad-based pricing to protect stressed consumerInnovation execution mixed—strong in cleaning and food, challenged in litter hard conversionGojo acquisition accretive to growth but dilutive to gross margin in year one

Risks management surfaced:

Middle East conflict and commodity volatility creating uncertain cost environment for FY27Litter category conversion taking longer than expected with shelf placement and velocity challengesConsumer stress from fuel prices and economic uncertainty pressuring discretionary category growthFood category experiencing mid-single-digit decline with competitor promotional intensity and GLP-1 consumer trend headwindsPrivate label share requiring continued monitoring despite current stabilization

Answers to last quarter's watch list

Household segment EBIT margin trajectory — Household EBIT margin rebuilt to 15.4% in Q3 FY2026 from 5.3% in Q2 FY2026, with EBIT of $74M on $482M of revenue. Revenue grew 3% YoY. The promotional intensity that crushed Q2 FY2026 margin appears to have moderated, and the segment is the cleanest positive in the print.

Resolved positively

Magnitude of "selective price investments" — Management did not quantify the net revenue management headwind in dollar terms, but the FY2026 adjusted EPS range was cut by $0.50 at the floor (from $5.95 to $5.45) and gross margin guidance tripled in deterioration magnitude. The FY range was lowered on EPS, organic sales, and gross margin.

Resolved negatively

Q3 FY2026 organic sales trajectory — Q3 organic landed at -1%, materially better than the -9% full-year pace but well short of the "positive low single digits" ex-ERP back-half inflection that anchored the FY guide. Crucially, FY2026 organic was simultaneously cut to -9% (worst end of prior range), confirming the back-half recovery thesis has broken.

Resolved negatively

Lifestyle segment continued softness — Lifestyle deteriorated to -9% YoY in Q3 FY2026 from -5% in Q2 FY2026, on a cleaner ERP-comp basis. EBIT margin held at 21.7% but revenue of $277M is the weakest segment trajectory in the portfolio. Charcoal and food/dressings seasonality is now a Q4 risk, not a Q4 catalyst.

Resolved negatively

Named innovation SKUs and distribution gains — The press release leaned on qualitative innovation language, with the litter category specifically called out as "bumpier" and a "hard conversion" that has "not proven yet" to be working. No specific SKUs, ACV gains, or scanner share data were disclosed. The innovation narrative remains rhetoric except in the negative — litter is now explicitly flagged as the failed innovation.

Resolved negatively

What to watch into next quarter

Q4 FY2026 gross margin print vs the new -250 to -300 bps FY guide: Q3 FY2026 came in at 43.2% (-140 bps YoY). To hit the new FY guide, Q4 FY2026 needs materially steeper gross margin compression than anything reported in prior quarters. Watch whether Q4 gross margin lands at or above ~41.5%, which would imply the new guide already embeds a cushion; a print below 41% would mean the gross margin walk is still deteriorating.

Litter franchise: stabilization or further break: management called the litter conversion "bumpier" and "not totally unexpected" while admitting it has "not proven yet." Watch for an explicit shelf placement, velocity, or share recovery data point at the Q4 print; absence of one would confirm the franchise is in extended repair.

FY27 guidance framework at Q4 FY2026: Bellet declined to commit to any FY27 framing this quarter, citing "wide range of scenarios." The Q4 FY2026 print is the first opportunity for an initial FY27 algorithm. Watch whether the company offers any preliminary range or punts again to the August call — a punt would signal continued visibility loss.

Oil-related commodity headwind size for FY27: Luke cited $20-25M of oil input cost pressure in Q4 alone from the Middle East conflict, with the FY27 commodity setup unresolved. A specific dollar quantification at Q4 FY2026 of how much of this carries into FY27 would frame the starting point for next year's margin walk.

Lifestyle revenue trajectory: -9% in Q3 FY2026 on a clean comp is the worst single-quarter underlying trend across the portfolio. Q4 FY2026 includes charcoal and food seasonality; a print at -5% or worse would mean the category has lost its seasonal lift entirely.

Sources

Clorox Q3 FY2026 press release, April 30 2026 — https://www.sec.gov/Archives/edgar/data/21076/000002107626000016/ex991-pressreleasedatedapr.htm
Clorox Q3 FY2026 earnings call commentary (tone shifts, guidance walk components, litter category framing, FY27 hedging)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.